市場調查報告書

胚胎著床前診斷市場 - 類型·終端用戶·各地區:市場規模·佔有率·展望·機會分析 (2020-2027年)

Preimplantation Genetic Diagnosis Market, By Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968788
出版日期 內容資訊 英文 188 Pages
商品交期: 2-3個工作天內
價格
胚胎著床前診斷市場 - 類型·終端用戶·各地區:市場規模·佔有率·展望·機會分析 (2020-2027年) Preimplantation Genetic Diagnosis Market, By Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年10月15日內容資訊: 英文 188 Pages
簡介

本報告提供全球胚胎著床前診斷 (PGD) 市場相關調查,提供市場概要,影響市場的因素分析,各市場區隔·各地區的市場分析,並提供主要企業簡介等資訊。

目錄

第1章 調查目的·前提條件

  • 調查目的
  • 假設
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各類型
    • 市場明細:各終端用戶
  • Coherent Opportunity Map (COM)

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的發展
  • 法規方案
  • PEST分析
  • COVID-19影響分析

第4章 全球胚胎著床前診斷市場:治療各類型

  • 簡介
  • 染色體異常
  • 染色體非整倍體
  • X連鎖遺傳病
  • 單一遺傳基因障礙
  • HLA型檢測
  • 性別selection (性別選擇)
  • 其他(障礙,成人發病型疾病)
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長率
    • 市場區隔趨勢

第5章 全球胚胎著床前診斷市場:各終端用戶

  • 簡介
  • 診斷研究所
  • 醫院
  • 診所
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長率
    • 市場區隔趨勢

第6章 全球胚胎著床前診斷市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 東南亞國協
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他南美國家
  • 中東
    • GCC各國
    • 以色列
    • 其他中東
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情形

  • 企業簡介
    • Amgen Inc.
    • Quest Diagnostics
    • Vertex
    • PerkinElmer, Inc.
    • F. Hoffman-La-Roche Ltd
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings
    • Abbott Laboratories
    • Illumina, Inc.
    • Natera Inc.
    • CooperGenomics Inc.
    • Reproductive Genetics Institute, Inc.
    • Genea Ltd.
    • Invitae Corporation
    • CombiMatrix Corporation

第8章 章節

目錄

Title:
Preimplantation Genetic Diagnosis Market, By Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single gene disorders, HLA Typing, Gender Selection, Others (for disability, adult onset disease)), By End User (Diagnostic Laboratories, Hospitals, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Preimplantation genetic diagnosis (PGD) is the genetic profiling of the pre implantable embryos and oocytes before their implantation. The preimplantation genetic diagnosis is similar to that of the parental diagnosis in case of screening for a particular genetic disease. The PGD is advantageous in a way that helps to avoid selective pregnancy termination by the development and growth of the healthy fetus. PGD serves as an addendum to assisted reproductive technology. The preimplantation genetic diagnosis is required in vitro fertilization, in order to obtain oocytes from the embryos for the genetic evaluation of the diseased or disease-free conditions. In simpler terms, the preimplantation genetic diagnosis is a technique that is used to identify embryos at risk.

Restraints of the Global Preimplantation Genetic Diagnosis Market

Major factors hampering the growth of the preimplantation genetic diagnosis market during the forecast period constitutes of non-availability of embryos for transfer.

Key features of the study:

  • This report provides in-depth analysis of the global preimplantation genetic diagnosis market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global preimplantation genetic diagnosis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Amgen, Quest Diagnostics, Genentech Inc., Vertex, PerkinElmer, Inc., F. Hoffman-La-Roche Ltd, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, Illumina, Inc., Natera Inc., CooperGenomics Inc., Reproductive Genetics Institute, Inc., Genea Ltd., Invitae Corporation, and CombiMatrix Corporation.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global preimplantation genetic diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Preimplantation Genetic Diagnosis Market, By Type:
    • Chromosomal Abnormalities
    • Aneuploidy
    • X-linked diseases
    • Single gene disorders
    • HLA Typing
    • Gender Selection
    • Others (for disability, adult onset disease)
  • Global Preimplantation Genetic Diagnosis Market, By End User:
    • Diagnostic Laboratories
    • Hospitals
    • Clinics
  • Global Preimplantation Genetic Diagnosis Market, By Geography:
    • North America
  • By Type
    • Chromosomal Abnormalities
    • Aneuploidy
    • X-linked diseases
    • Single gene disorders
    • HLA Typing
    • Gender Selection
    • Others (for disability, adult onset disease)
  • By End User
    • Diagnostic Laboratories
    • Hospitals
    • Clinics
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Type
    • Chromosomal Abnormalities
    • Aneuploidy
    • X-linked diseases
    • Single gene disorders
    • HLA Typing
    • Gender Selection
    • Others (for disability, adult onset disease)
  • By End User
    • Diagnostic Laboratories
    • Hospitals
    • Clinics
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Type
    • Chromosomal Abnormalities
    • Aneuploidy
    • X-linked diseases
    • Single gene disorders
    • HLA Typing
    • Gender Selection
    • Others (for disability, adult onset disease)
  • By End User
    • Diagnostic Laboratories
    • Hospitals
    • Clinics
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Type
    • Chromosomal Abnormalities
    • Aneuploidy
    • X-linked diseases
    • Single gene disorders
    • HLA Typing
    • Gender Selection
    • Others (for disability, adult onset disease)
  • By End User
    • Diagnostic Laboratories
    • Hospitals
    • Clinics
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Type
    • Chromosomal Abnormalities
    • Aneuploidy
    • X-linked diseases
    • Single gene disorders
    • HLA Typing
    • Gender Selection
    • Others (for disability, adult onset disease)
  • By End User
    • Diagnostic Laboratories
    • Hospitals
    • Clinics
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Type
    • Chromosomal Abnormalities
    • Aneuploidy
    • X-linked diseases
    • Single gene disorders
    • HLA Typing
    • Gender Selection
    • Others (for disability, adult onset disease)
  • By End User
    • Diagnostic Laboratories
    • Hospitals
    • Clinics
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Amgen Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Quest Diagnostics
    • Vertex
    • PerkinElmer, Inc.
    • F. Hoffman-La-Roche Ltd
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings
    • Abbott Laboratories
    • Illumina, Inc.
    • Natera Inc.
    • CooperGenomics Inc.
    • Reproductive Genetics Institute, Inc.
    • Genea Ltd.
    • Invitae Corporation
    • CombiMatrix Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global Preimplantation Genetic Diagnosis Market, By Type, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Chromosomal Abnormalities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Aneuploidy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • X-linked diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Single gene disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • HLA Typing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Gender Selection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Others (for disability, adult onset disease)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Preimplantation Genetic Diagnosis Market, By End User, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Preimplantation Genetic Diagnosis Market, By Regions, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

    • Company Profiles
  • Amgen Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vertex
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffman-La-Roche Ltd
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratory Corporation of America Holdings
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Natera Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CooperGenomics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reproductive Genetics Institute, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genea Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Invitae Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CombiMatrix Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

    • References
    • Research Methodology
    • About us and Sales Contact